GENE is the ticker symbol for Genetic Technologies Ltd, a biotechnology company that develops genetic risk assessment tests for various diseases1. According to Nasdaq, GENE was up 14.29% in pre-market trading as of Nov 01, 20212. One possible reason for this surge is the company’s announcement on Oct 29, 2021, that it had received a patent from the US Patent and Trademark Office for its breast cancer risk test3. This test, called GeneType for Breast Cancer, uses a combination of genetic and clinical factors to estimate a woman’s lifetime risk of developing breast cancer3. The patent is expected to strengthen the company’s intellectual property portfolio and enhance its market position in the US3.
1: Genetic Technologies Ltd ADS (GENE) Pre-Market Quotes | Nasdaq 2: (GENE) Latest Pre Market Trades | Nasdaq 3: Genetic Technologies Ltd. Announces Issuance of U.S. Patent for Breast Cancer Risk Test
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| GTG (ASX) Chart |
Day chart unavailable